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Title: Predictors of quality of life gains among people with type 1 diabetes participating in 
the Dose Adjustment for Normal Eating (DAFNE) structured education programme 
Abstract    
Aims: To examine predictors of quality of life gains among people with type 1 diabetes 
following DAFNE (Dose Adjustment for Normal Eating) self-management training 
programme. 
Methods: Clinical and questionnaire data were collected from 437 patients from 6 hospital 
centres before, and at 18 month post, DAFNE intervention. Glycated haemoglobin (HbA1c), 
weight and height, and blood pressure levels were recorded by clinicians during clinic 
appointments. Questionnaires included the Diabetes-Specific Quality of Life Scale (DSQOLS), 
the Problem Areas in Diabetes Scale (PAID) and the Hospital Anxiety and Depression Scale 
(HADS). Basic demographics were recorded at baseline. Linear mixed models were fitted to 
identify predictors of change in quality of life at 18 month follow up. 
Results: Those with high levels of diabetes-related distress experienced greatest 
improvement in DSQOLS quality of life scores (p=0.001).  Those with poor glycaemic control 
(higher levels of HbA1c; p=0.03) and those with high levels of anxiety (p=0.001) experienced 
greatest reductions in diabetes-related distress. 
Conclusions: Those with higher baseline levels of anxiety, higher levels of diabetes-related 
distress and higher baseline levels of HbA1c are most likely to experience quality of life gain 
from participation in self-management programmes like DAFNE.  
Keywords: Diabetes mellitus type 1; Quality of Life; Predictors; Self-management 
programmes; DSQOLS 
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Introduction 
Type 1 diabetes is a chronic disease in which individuals are unable to produce insulin, 
which is essential for regulating blood sugar. As a result, those with type 1 diabetes need to 
carry out daily blood sugar monitoring and insulin injections to maintain tight glycaemic 
control in order to avoid diabetic complications. Many people with diabetes find their 
complex daily monitoring and medication regimen challenging and stressful to maintain 1, 
especially as tight control can result in hypoglycaemia (abnormally low blood sugar levels) 
posing a serious health threat. 
Quality of life has been shown to be lower in those with diabetes compared to similar 
individuals without diabetes 2. Those with type 1 diabetes also show a faster rate of decline 
in quality of life over time when compared to the general population 3.  
 
Self-management training programmes have been shown to result in a number of positive 
outcomes for people with type 1 diabetes. Although clinical indicators, such as glycated 
haemoglobin (HbA1c), are most commonly used as markers of the success of interventions, 
the importance of psychological indicators of success (such as quality of life) has been 
stressed4-5.  One of the most consistent findings in the literature is that self-management 
training programmes result in increased quality of life among people with diabetes 6.  
The Dose Adjustment for Normal Eating (or DAFNE) programme is a self-management 
training programme for individuals with type 1 diabetes 7. DAFNE is a five-day outpatient 
programme which employs principles of adult learning and takes place in a group setting. 
The programme promotes dietary freedom, aiming to empower participants with the skills 
to enable them to replace insulin in a way which suits their current lifestyle rather than 
having to rigidly adapt the timing and content of meals to more fixed doses of insulin. 
DAFNE has been shown to result in significant improvements in quality of life and glycaemic 
control in people with type 1 diabetes, without worsening severe hyperglycaemia or 
cardiovascular risk 7. Indeed, improvements in quality of life have been shown to be 
maintained at four years post DAFNE intervention 8. 
There is little published research exploring factors which predict increases in quality of life 
associated with participation in diabetes self-management training programmes. It is likely 
that individual characteristics of programme participants will affect how well they engage 
with the programme and how much they benefit from participation. Negative attitudes, 
coping difficulties and psychological problems such as depression and anxiety have been 
shown to present barriers to effective self care among those with diabetes 9. It is important 
for service providers to be aware if there are particular categories of patients who are likely 
to benefit from participation in the self management programmes more than others. This 
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information also enables providers to identify individuals who may need additional support 
to benefit from their programmes.  
In the Irish DAFNE Study 10, we showed improvements in (1) perceived burden of diabetes 
(measured by PAID) and (2) both the total quality of life and treatment satisfaction scores 
on the DSQOLS among a cohort of 437 DAFNE graduates, at 18 month follow up post 
participation in the DAFNE intervention. From baseline to 18 month follow up, PAID scores 
decreased on average by 9.13 percentage points, where lower scores indicated lower levels 
of distress (95% CI -10.63 to -7.64, p<0.001). From baseline to 18 month follow up, DSQOLS 
treatment satisfaction scores increased on average by 2.61 percentage points (95% CI 1.80 
to  3.43, p<0.001) and DSQOLS quality of life scores increased on average by 9.23 
percentage points (95% CI 7.56 to 10.90, p<0.001). Higher scores on DSQOLS indicate a 
higher level of quality of life.  
The aim of this paper is to examine which baseline characteristics (including age, gender, 
marital status, education level, smoker/non-smoker, years since diagnosis, body mass index, 
blood pressure recordings, HbA1c, anxiety (HADS-A) and depression (HADS-D)) predict level 
of improvements in health related quality of life (as measured by PAID and DSQOLS) at 18 
month follow up. 
Subjects and methods 
Detail of the study methodology for the Irish DAFNE Study has been published elsewhere 11. 
Briefly, six outpatient hospital diabetes clinics delivering the DAFNE programme on the 
island of Ireland participated. Four hundred and thirty-seven study participants were 
recruited from waiting lists of individuals who had expressed an interest in receiving DAFNE 
training in participating centres. Sixty two patients from the DAFNE training waiting list were 
not recruited as they did not meet the inclusion criteria. Recruitment commenced in 
October 2006 and finished in February 2009. Inclusion criteria were broad and included a 
diagnosis of type 1 diabetes of at least 12 months duration, the ability to read and speak 
English, a willingness to engage in regular self-monitoring of blood glucose and a glycated 
haemoglobin (HbA1c) level below 13 percent at recruitment. Participants had to be using a 
basal/bolus insulin regimen or be willing to convert to such a regimen prior to participation. 
Patients were excluded if they had advanced diabetes complications, were pregnant or 
planning pregnancy in the next 2 years, were currently using an insulin pump to manage 
their diabetes or had significant co-morbidities likely to interfere with study participation. 
Data were collected from participants at baseline (taken one week prior to receiving DAFNE) 
and at 18 months post DAFNE training. Data were collected for 415 participants at 18 month 
follow up. Approval was obtained from Research Ethics Committees in each hospital. 
Materials 
DAFNE Intervention 
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The content and organisation of the education delivered to patients within the DAFNE 
programme has been described in detail elsewhere 12. In short, DAFNE consists of 38 hours 
of skills based structured education provided over five consecutive days in an outpatient 
setting, to groups of six to eight people with type 1 diabetes. The principal aim is to facilitate 
autonomy, competency and confidence in the self-management of diabetes by providing 
skills-based training in the areas of carbohydrate counting and insulin dose adjustment in a 
comprehensive range of situations. It encourages a liberal approach to diet but emphasises 
matching of quick-acting insulin to food.  
The Irish DAFNE Study was a randomised controlled trial comparing two different methods 
of follow up after DAFNE intervention. Participants in control arm centres were invited back 
to traditional clinic visits where they received one-to-one visits with a doctor, nurse and/or 
dietician. Follow-up care in intervention arm centres involved participants returning in their 
original group and receiving “booster” group education sessions from DAFNE educators at 6 
and 12 months post DAFNE.  
Measures 
Quality of life data 
Quality of life was assessed using two diabetes specific instruments, the Diabetes-Specific 
Quality of Life Scale (DSQOLS) and the Problem Areas in Diabetes (PAID) Scale.  
The DSQOLS is a reliable and valid measure of quality of life specific for people with type 1 
diabetes 13. It consists of 2 sections: the treatment satisfaction score and the quality of life 
score. Scores are reported on a percentage scale, with a higher score indicating higher 
satisfaction and quality of life.  
The PAID Scale 14-15 is a widely used measure of psychosocial adjustment to diabetes. Scores 
are reported on a percentage scale, with higher scores indicating higher levels of diabetes 
related distress. A cut-off score of ≥33 on the indicates clinically significant high levels of 
distress 16.  The psychometric properties of the PAID Scale have been established 17.  
Although the PAID Scale is not a specific quality of life measure, it was included as it has 
been suggested that the inclusion of a diversity of measures of quality of life type variables 
may improve the validity of the quality of life construct 6.   
Clinical and demographic data 
Glycated haemoglobin (HbA1c) was measured centrally in a laboratory with a track record of 
supporting large multi-centre studies. The method used was a DCCT-aligned HPLC assay 
(ADAMS-A1c HA-8160). Weight (measured to the closest gram on a Seca Medical Scales) and 
height (measured to the closest cm by a stadiometer) was used to assess baseline body 
mass index and blood pressure levels were recorded using a digital clinical blood pressure 
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monitor. Age, gender, marital status, education level, years since diagnosis and smoking 
status were recorded at baseline.  
Psychological data 
Anxiety and depression were measured using the Hospital Anxiety and Depression Scale 
(HADS) 18. Total scores for anxiety and depression range from 0 to 21, with higher scores 
indicating higher levels of symptomatology. Various cut-off points have been used, though 
Zigmond and Snaith recommend a cut-off score of 8 for both scales to include all possible 
cases. The psychometric properties of the HADS have been confirmed 19. 
Data analysis 
A linear mixed model was fitted to identify predictors of improvement in quality of life (as 
measured by PAID and DSQOLS) at 18 month follow up, while adjusting for cluster structure 
due to hospital centre.  
The choice of which predictor variables to include in the model was determined a priori, 
age, gender, marital status, smoker/non-smoker, educational status, years since diagnosis, 
body mass index, blood pressure, HbA1c and the psychological variables relating to anxiety 
(HADS-A), depression (HADS-D) and quality of life (DSQOLS, PAIDS).  Given the correlation 
between the psychological variables multicollinearity was an issue when including all 
psychological variables in the final model. To correct for this, variable selection techniques 
and regression tree models were used to identify the most useful psychological variables for 
inclusion.  
Missing data were dealt with by multiple imputation using a Bootstrap Based Method20 
where each missing value was replaced by 5 imputed values.  Continuous Reponses were 
transformed for Normality as necessary.  In order to compare the sensitivity of the overall 
conclusions to missingness the results of each ‘complete’ model (i.e. with imputed values) 
were pooled using the Barnard-Rubin adjustment method21.   
 
The assumptions underlying each model were checked using suitable residual plots. All 
analyses were performed using R version 2.10. 
 
Results 
Demographic and clinical characteristics of the sample are shown in Table 1. Overall 
participants are on average 40 years of age and have been diagnosed with type 1 diabetes 
for around 15 years. Just over half the sample are female (54%), the majority are married 
(62%) and nearly half the sample have completed 3rd level education (48%). 
+++ Table 1 here +++ 
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For each participant, the response variables (change in PAID score and change in DSQOLS 
quality of life score) were calculated as the improvement at 18 months follow-up compared 
to the score at baseline.  
Table 2 shows the results of the two linear mixed models to identify predictors of 
improvement in PAID and DSQOLS scores.  
+++ Table 2 here +++ 
Predicting changes in PAID scores 
Participants with higher HbA1c levels at baseline exhibited a greater improvement in PAID 
score (i.e. greater reduction in diabetes-related distress levels) as shown by the positive 
coefficient for HbA1c and p-value = 0.03. Participants with higher HADS anxiety scores at 
baseline also exhibited a greater decrease in PAID score (p-value = 0.001). No other 
variables significantly predicted changes in PAID scores within this model and when using 
Multiple Imputation. 
 
Predicting changes in DSQOL QOL scores 
Participants with higher PAID scores at baseline showed increased DSQOLS scores (i.e. an 
improvement in quality of life) as shown by the positive coefficient for PAID score at 
baseline and p-value = 0.001. No other variables significantly predicted changes in DSQOLS 
scores within this model and when using Multiple Imputation. 
 
Discussion 
This paper aims to explore whether there are baseline variables which predict health related 
quality of life gains as a result of participating in a self-management training programme for 
people with type 1 diabetes. In line with previous research 7, participants in the Irish DAFNE 
Study experienced significant improvements in diabetes specific quality of life related 
measures (PAID and DSQOLS) as a result of participation in the programme, which were 
maintained at 18 month follow up. The improvements observed in our study compare 
favourably to those found in other interventions studies 22. 
In summary, those with higher levels of diabetes-related distress experienced significantly 
greater improvement in DSQOLS quality of life scores than those with lower levels of 
diabetes-related distress. In addition, those with poorer levels of glycaemic control (higher 
levels of HbA1c) and those with higher levels of anxiety as measured by the HADS at 
baseline, experienced significantly greater reductions in diabetes-related distress than those 
with better levels of glycaemic control or those with lower levels of anxiety.  
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With regard to the finding that those experiencing greater levels of diabetes-related distress 
at baseline experience greater quality of life gains as a result of participating in the DAFNE 
programme, this makes sense, as this group presumably have more scope for improvement 
than those with lower levels of diabetes-related distress. The finding that those with higher 
levels of anxiety as measured by the HADS at baseline, experienced significantly greater 
reductions in diabetes-related distress than those with lower levels of anxiety at baseline, 
also fits in with this finding. Research has shown that diabetes and high anxiety levels 
frequently coexist23. In the current sample, around a quarter of patients reported levels of 
anxiety at baseline that would be considered to indicate clinically elevated levels.  These 
findings suggest that, where resources are limited and only a limited number of patients can 
be offered a place on a self-management programme, baseline PAID scores or HADS anxiety 
scores may be used effectively to select those who will benefit most from participation in 
the programme.  
Poor glycaemic control predicted reductions in diabetes-related distress but not 
improvements in DSQOLS quality of life scores. Those with poorer glycaemic control 
experienced significantly greater reductions in diabetes-related distress as a result of 
participating in our programme. Previous studies examining the relationships between 
glycaemic control and quality of life in cross-sectional studies have reported inconsistent 
findings. For example, in a large review paper Rubin and Peyrot 24 reported that better 
glycaemic control is associated with better quality of life, however, such a relationship was 
not found by Redekop and colleagues when they controlled for other factors in multivariate 
analysis 25. Specifically examining the impact of therapeutic education on quality of life, 
Debaty and colleagues 26 found that among a group on adults with type 1 diabetes, those 
with poorer glycaemic control before the programme appeared to derive greater benefit 
from therapeutic education.  
In the current study, although it is not statistically significant, there is a suggestion that 
those with a higher level of educational attainment (having completed 3rd level education; 
coefficient for DSQOLS score 5.68, p=0.07) experienced greater increases in quality of life 
(improvement in DSQOLS score) as a result of participation in the programme compared 
with those with lower levels of educational attainment (having completed 
secondary/highschool education only). Previous research has suggested that lower 
socioeconomic status, as measured by income or educational level, has been a robust 
predictor of lower levels of quality of life among people with diabetes 24. Our study suggests 
that those who have lower educational attainment may not gain as much from participating 
in a self-management programme and may suggest that such programmes are targeted at 
more educated patients. The methods of insulin adjustment taught as part of DAFNE require 
reasonable English literacy and numeracy, which may exclude some patients. Patients with 
lower educational attainment levels may benefit from further supports being put into place 
when participating in DAFNE or similar programmes. Further research is required to confirm 
this suggestion however.  
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Two other variables approach significance as predictors of quality of life gain: marital status 
(being single/widowed compared to being married; coefficient for DSQOLS score -4.99, 
p=0.06) and smoking status (being a regular smoker compared to a non-smoker; coefficient 
for PAID score 6.88, p=0.06). The suggestion that single people are more likely to gain from 
participation in the programme is likely to be caused by random variation as there are only a 
small number of single participants included in the model. The suggestion that smokers gain 
more than non-smokers from participation may well point to a real relationship, as it could 
be expected that smokers have more to gain from a programme aiming to improve self-
management of risk factors. Current smoking has been shown to predict significantly lower 
quality of life among those with type 2 diabetes27. If this finding were replicated in the 
current sample, then there is more scope for improving quality of life among smokers than 
non-smokers. This relationship would need to be explored further in research to be 
confirmed. 
It is of interest that a number of other variables examined, for example duration of diabetes, 
age, gender, marital status and body mass index do not appear to significantly predict 
quality of life gains as a result of participating in DAFNE. This suggests that, in general, self-
management training programmes are effective in improving quality of life across a broad 
range of people with type 1 diabetes.  
A limitation of the current study is that we were not testing a priori hypotheses regarding 
relationships between study variables, and therefore our findings should be interpreted 
with some caution. As one might expect, multicollinearity was observed when including all 
psychological variables in our models, so we had to select variables for inclusion to make the 
most parsimonious subset of variables for the final models. Some degree of subjective 
judgement was involved in this process. This may mitigate the strength of some of the 
relationships reported. 
In conclusion, our study suggests that, where resources are stretched and only a limited 
number of patients can be offered a place on a self-management programme, those with 
higher baseline levels of anxiety, higher baseline levels of diabetes related distress and 
higher baseline levels of HbA1c are more likely to benefit most (in terms of quality of life 
gain) from participation in the programme. These findings are significant especially as those 
experiencing elevated levels of anxiety or distress may be more likely to be deemed 
‘unsuitable’ by educators for participation in a self management programme.   
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Table 1 Demographic, clinical and psychological characteristics of study participants at 
baseline (n=437) 
 Mean SD 
Age (years) 40.8 11.7 
Years since diagnosis  15.9 10.8 
Baseline BMI (kg/m
2
) 26.0 4.1 
Systolic BP (mmHg) 124.9 18.9 
Diastolic BP (mmHg) 74.1 10.9 
Baseline HbA1c (%) 8.3 1.4 
 Number % 
Gender 
- Female  
- Male    
 
235 
202 
 
53.8% 
46.2% 
Married 236/ 378 62.43% 
Education 
- Completed 3
rd
 level 
178/371 48.0% 
Occupation 
- Employed 
- Retired  
- Other 
 
277/379 
11 
91 
 
73.1% 
2.9% 
24.0% 
No. of regular/ occasional smokers 79/ 382 20.7% 
Self-reported diabetic complications 93/ 434 21.4% 
Baseline HADS Anxiety < 8 326/ 427 76.4% 
Baseline HADS Anxiety 8 – 11  78/ 427 18.3% 
Baseline HADS Anxiety > 11 23/ 427 5.4% 
Baseline HADS Depression < 8 355/ 426 83.3% 
Baseline HADS Depression 8 – 11  56/ 426 13.2% 
Baseline HADS Depression > 11 15/ 426 3.5% 
Baseline PAID > 33 166/ 423 39.2% 
Baseline PAID < 32 257/ 423 60.8% 
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 Table 2 Linear mixed models to estimate strength of study variables to predict 
improvements in PAIDS and DSQOLS from baseline to 18 month follow-up  
  
Improvement in 
PAID Score   
Improvement in 
DSQOLS  
        
Explanatory Variable Coef. 
Estimated  
Standard 
Error p-value  Coef. 
Estimated  
Standard 
Error p-value 
HbA1c 1.86 0.86 0.03  0.05 0.87 0.95 
Age 0.08 0.12 0.47  0.04 0.13 0.73 
Gender (Female) -1.54 2.26 0.50  -1.17 2.29 0.61 
Years with disease -0.13 0.11 0.22  -0.01 0.11 0.95 
Systolic blood pressure -0.01 0.08 0.85  -0.04 0.08 0.65 
Diastolic blood pressure 0.03 0.14 0.80  0.01 0.14 0.98 
Marital Status (Married/Partner)        
        Separated/Divorced -1.66 5.75 0.77  3.50 6.7 0.60 
        Single/Widowed -1.65 2.54 0.52  -4.99 2.65 0.06 
Education Level (Completed Second Level)        
        Primary/Some Second Level -0.48 4.06 0.91  1.83 4.04 0.65 
        Some Third Level 0.65 3.53 0.85  2.12 3.56 0.55 
        Completed Third Level 2.70 3.14 0.39  5.68 3.13 0.07 
Smoking Status (Non-smoker)        
        Ex-smoker 0.85 2.75 0.76  -0.09 2.83 0.97 
        Occasional 6.59 3.86 0.09  6.58 4.09 0.11 
        Regular 6.88 3.61 0.06  0.74 3.91 0.85 
BMI 0.26 0.27 0.33  0.48 0.27 0.08 
HADS Anxiety Score 0.96 0.30 0.001  - - - 
PAID Score - - -  0.29 0.06 0.001 
 
* Bold values are statistically significant, i.e. p-value ≤ 0.05. 
The reference categories for gender, marital status, education level and smoking status are given in 
brackets. 
* - indicate that this variable was not deemed necessary for inclusion in the model 
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